AVM surgery is an operation to remove or close off an arteriovenous malformation, an abnormal tangle of blood vessels in the brain where arteries connect directly to veins without the normal network of tiny capillaries in between. Because this tangle can rupture and cause life-threatening bleeding, surgery aims to eliminate it entirely. There are three main approaches: open surgical removal (microsurgery), catheter-based treatments that seal the vessels from inside, and focused radiation that gradually shrinks the malformation over years.
What an AVM Is and Why It Needs Treatment
In a normal brain, arteries carry high-pressure blood through progressively smaller vessels until it reaches capillaries, where pressure drops before blood enters the veins. An AVM skips this step. High-pressure arterial blood flows directly into thin-walled veins that aren’t built to handle it. Over time, those veins can stretch, weaken, and eventually burst.
The annual risk of bleeding is roughly 2.2% for an AVM that has never ruptured and about 4.5% for one that has bled before. That may sound small in any given year, but the risk accumulates over a lifetime, especially for younger patients. Other factors that raise the bleeding risk include veins that drain deep into the brain rather than toward the surface, a location deep within brain tissue, and the presence of an associated aneurysm. Previous rupture is the single strongest predictor of future bleeding, with the annual risk roughly tripling compared to an unruptured AVM.
How Doctors Decide Whether to Operate
Not every AVM needs surgery. The decision hinges on a grading system developed by neurosurgeons Spetzler and Martin that scores an AVM on three features: its size (under 3 cm, 3 to 6 cm, or over 6 cm), whether it sits in a part of the brain that controls critical functions like movement, speech, or vision, and whether its veins drain into the deep brain or toward the surface. The resulting score, from 1 to 5, predicts how risky surgery would be.
Grades 1 and 2 (grouped as Class A) are the most favorable. These patients are typically offered surgery when they’re otherwise healthy and have many years of life ahead. Grade 3 (Class B) may be offered surgery if the AVM has a compact, well-defined shape or if the patient is younger than 40. For diffuse grade 3 AVMs in older patients, focused radiation is often preferred. Grades 4 and 5 (Class C) are generally left alone unless the patient is very young or has severe, uncontrolled seizures and accepts the risk of permanent neurological problems. One notable exception: a ruptured grade 4 AVM in a patient under 20 with a compact shape may still warrant surgery, as studies show adverse outcomes of only about 10% in that specific group.
Open Microsurgery
Microsurgery is considered the gold standard for treating brain AVMs. A neurosurgeon opens the skull (craniotomy), identifies the tangle of abnormal vessels under a high-powered microscope, carefully disconnects the feeding arteries, and removes the entire malformation. The goal is complete removal in a single operation.
For small AVMs under 3 cm, complete removal succeeds in more than 94% of patients, with good overall outcomes in over 90% of cases. Results drop off sharply for larger, more complex malformations. Total excision is possible in only about 22% of grade 4 AVMs and 17% of grade 5. That steep decline is exactly why the grading system matters so much in deciding who should have open surgery.
Before operating, the surgical team maps the brain in detail. Digital subtraction angiography, a specialized X-ray that highlights blood vessels in real time, shows the exact architecture of the AVM: which arteries feed it, where the veins drain, and how large the core is. Functional MRI can identify whether critical brain areas for language or movement sit near the malformation, though its accuracy can be reduced by the abnormal blood flow patterns that AVMs create. In some cases, additional testing is needed to confirm what fMRI suggests.
Endovascular Embolization
Rather than opening the skull, this approach works from inside the blood vessels. A doctor threads a thin catheter from an artery in the groin up into the brain, navigating it into the vessels feeding the AVM. Once in position, the catheter delivers a liquid sealing agent that hardens inside the abnormal vessels and blocks blood flow.
The two most commonly used agents are an ethylene-vinyl alcohol copolymer (sold as Onyx) and a fast-setting surgical glue called n-butyl cyanoacrylate. Onyx comes in several thicknesses and solidifies when it contacts blood, forming a solid cast inside the vessel. Both agents are mixed with materials that make them visible on X-ray so the doctor can watch exactly where they flow during the procedure.
Embolization alone achieves complete closure of the AVM in only about 13% of patients. Its real value is as a first step before microsurgery or radiation. By sealing off some of the feeding arteries ahead of time, it shrinks the AVM, reduces blood flow through it, and makes the subsequent procedure safer and more manageable. Complications from embolization occur in roughly 7% of cases.
Stereotactic Radiosurgery
Despite the name, this isn’t surgery in the traditional sense. Stereotactic radiosurgery uses highly focused beams of radiation aimed at the AVM from multiple angles, concentrating a high dose on the abnormal vessels while sparing surrounding brain tissue. The most widely used system is the Gamma Knife.
Radiation doesn’t destroy the AVM immediately. Instead, it damages the inner lining of the abnormal blood vessels, triggering a slow process of scarring and thickening that gradually closes them off. Complete obliteration typically takes 3 to 5 years, and success rates during that window range from 60% to 80% after a single treatment session. Smaller AVMs respond better; the success rate inversely correlates with size. For AVMs too large, too deep, or too close to critical brain structures for safe open surgery, radiosurgery is often the best or only option.
The most common side effect is radiation-induced swelling around the AVM, which typically appears 6 to 18 months after treatment and before the AVM has fully closed. This swelling may result from direct tissue irritation or from changes in blood drainage as vessels begin to scar shut. It can cause temporary neurological symptoms, though for most patients these resolve as the swelling subsides.
Risks and Complications
The primary surgical risks are bleeding, swelling, and damage to surrounding brain tissue. For complex grade 4 AVMs treated with open surgery, complication rates in matched studies reach about 32%. The complication rate for radiosurgery on the same grade is comparable, around 39%, though the types of complications differ. Surgery carries a more immediate risk of bleeding during or just after the operation, while radiosurgery complications tend to emerge months later.
One specific concern after open surgery is a phenomenon where the brain tissue surrounding the removed AVM suddenly receives more blood flow than it can handle. For years, the blood vessels near an AVM adapt to low pressure because the malformation diverts so much flow. Once the AVM is gone, normal blood pressure rushes into vessels that have lost their ability to regulate it properly. This can cause swelling or bleeding in the days after surgery, which is why blood pressure is kept tightly controlled in the intensive care unit afterward, often targeting a systolic pressure around 110 mmHg.
What Recovery Looks Like
After open microsurgery, you’ll spend time in the ICU where your blood pressure and neurological function are monitored closely. Fatigue is one of the most common complaints in the weeks that follow. Most people can return to many of their usual activities within 4 to 6 weeks, but full recovery typically takes 2 to 6 months. The wide range reflects differences in AVM size, location, whether a rupture occurred before surgery, and each person’s baseline health.
Recovery from embolization is generally shorter since there’s no incision in the skull, though you’ll still need monitoring for at least a day or two. Recovery from radiosurgery involves the least immediate downtime (many patients go home the same day), but the treatment itself takes years to work, and follow-up imaging is needed regularly to track whether the AVM is closing as expected.
Regardless of the approach, follow-up angiography is essential to confirm the AVM is completely gone. Even a small remnant can regrow or bleed. For microsurgery patients, this is usually done shortly after the operation. For radiosurgery patients, imaging continues for several years until complete obliteration is confirmed or retreatment is considered.